Aim: Current study aimed to investigate the sex-stratified secular trend of cardiovascular disease risk factors among an older population in Iran during a median follow-up period of 8.76 years.
Introduction
The world's older population has been increasing rapidly. 1 In addition, population age structures are expected to change dramatically over the forthcoming decades, with older populations projected to constitute 21.1% of the total global population by 2050.
1 Similarly, the Middle East is going through an important health transition. Aging and population growth, as well as improvements in life expectancy and other health indicators, will have a major influence on the region's health and resources, particularly among low-and middle-income countries, such as Iran. 2 It is worth noting the high prevalence, morbidity and mortality of cardiovascular diseases (CVD) in general and in older populations in Iran and the Middle East. [3] [4] [5] [6] Many studies have shown trends in CVD risk factors in general populations in most regions of the world, but there are few studies in older populations. 7 It is therefore difficult to generalize the efficacy of preventive programs to this group. Thus, the objective of the present study was to investigate sex-stratified secular trends of traditional CVD risk factors (i.e. general and central adiposity, hypertension, diabetes, chronic kidney disease, hyperlipidemia, low physical activity, and smoking) among an older population in a large community-based longitudinal study of a Middle East population, the Tehran Lipid and Glucose Study.
Methods

Study participants
Detailed descriptions of the Tehran Lipid and Glucose Study and data collection methods have been reported elsewhere. 8 Briefly, the Tehran Lipid and Glucose Study is a community-based prospective cohort study carried out on a representative sample of Tehran, the capital city of Iran. A multistage stratified cluster random sampling technique was used to select >15 000 people aged >3 years from urban district #13 of Tehran. The sampling frame was chosen from the urban district #13 of Tehran for two important reasons: (i) the stability of the population residing in that district is high; (ii) the age distribution of the population of district #13 is representative of the overall population of Tehran. Data collection was started in 1999-2001 (phase 1) and is ongoing on a triennial basis, designed to continue for at least 20 years. In the current study, data of participants who participated in phase 2 (2002-2005) were used. From a total of 1754 individuals aged ≥60 years at the examination date of phase 2264, participants without any follow up were excluded. The remaining 1490 participants with at least one follow up were included in the analyses. Hence, 84.9% of eligible baseline participants (1490/1754) were included in the current study. All participants completed a written consent form after being informed about the general aspects of the work, and the study was approved by the ethical committee of the Research Institute for Endocrine Sciences. A summary of clinical and laboratory measurements (i.e. general information, medical history, physical activity, anthropometrics, blood pressure, biomarkers) has been reported in Supplementary File 1. Furthermore, the definitions of terms were summarized in Table 1 as well as Supplementary File 1.
Statistical analyses
The baseline characteristics of participants were reported as the mean (standard deviation [SD]) for numerical variables and frequency (%) for categorical measures. Comparisons of baseline characteristics between men and women were carried out by the χ 2 -test for categorical variables, and Student's t-test for continuous variables. As triglyceride (TG) levels had a log-normal distribution, the mean (SD) of natural logarithm of TG level at baseline examination was summarized and compared by the Student's t-test.
To assess the secular longitudinal trends of continuous variables, which are fasting plasma glucose (FPG), highdensity lipoprotein cholesterol (HDL-C), TG, total cholesterol, non-HDL-C, low-density lipoprotein cholesterol (LDL-C), waist circumference (WC), waist-to-hip ratio, systolic blood pressure, diastolic blood pressure, body mass index and estimated glomerular filtration rate, and dichotomous variables, which are diabetes, low HDL-C, hypertriglyceridemia, high non-HDL-C, high LDL-C, hypertension, general and central obesity, current smoking, chronic kidney disease (CKD), low physical activity, and medication consumption, linear and logistic generalized estimating equation (GEE) models with an exchangeable working correlation matrix and robust standard errors were fitted, respectively. The trends for glucose-lowering and antihypertensive medications were assessed in diabetic and hypertensive subsamples, respectively, whereas the secular trends for lipid-lowering medications were reported in the whole sample size. Models for assessment of time trend were fitted separately for men and women, and age-adjusted marginal means and P-values for trend were reported. The effect modification of sex on the trend of risk factors was tested by fitting a model including sex, the risk factor and their cross-product in a pooled model including both sexes. P-values for interaction were calculated using the Wald test. All analyses were carried out using Stata statistical software (version 12 SE; StataCorp, College Station, TX, USA). P-values <0.05 were considered significant. Table 2 by sex. Women had higher FPG, HDL-C, TG, total cholesterol, non-HDL-C, LDL-C, WC, body mass index, systolic blood pressure and diastolic blood pressure level at baseline examination; however, they were younger and had lower smoking rates. The baseline characteristics of the respondents and nonrespondents are compared in Supplementary Table S1 . Generally, there was no clinically major difference between respondents and non-respondents. Figure 1 shows age-adjusted trends of anthropometrics and blood pressure measures, as well as lipid and glucose profiles of participants by sex. The population average serum level of FPG, HDL-C, WC, waist-to-hip ratio, diastolic blood pressure and body mass index increased significantly in both sexes. In contrast, participants' TG, total cholesterol, non-HDL-C, LDL-C and estimated glomerular filtration rate decreased significantly at the same period. Systolic blood pressure remained almost steady in both sexes throughout the study period. Figure 2 shows the secular trends in age-adjusted prevalence of CVD risk factors (dichotomous risk factors) in both sexes. The age-adjusted prevalence of diabetes, hypertension, central obesity and CKD had a noticeable upward trend during the study period in both sexes. The increasing trend for obesity was more prominent in women (P-value = 0.001). In contrast, lipid disorders in both sexes and low physical activity in men showed a downward trend. The age-adjusted prevalence of low HDL-C, hypertriglyceridemia, high non-HDL-C and high LDL-C showed decreasing trends in both sexes. The decreasing trends in high non-HDL-C and high LDL-C were more prominent in women. Although the age-adjusted prevalence of low physical activity decreased from 40% to 26% in men, it remained almost steady in women, with the prevalence of almost 50% during the study period. Values are presented as mean (SD) unless otherwise indicated. Table 3 shows the crude and age-adjusted secular trend of drug consumption. In hypertensive and diabetes patients, there were increasing trends in antihypertensive and glucose-lowering drugs consumption during the study. The increasing trend in antihypertensive drug consumption was more prominent in men. The lipid-lowering drugs consumption showed more prominent increasing trends from 4% in men and 10% in women at baseline to 26% and 41% at the latest follow up.
For sensitivity analysis, we repeated the GEE analyses in the CVD-free participants (n = 1023). The results were similar after exclusion of those with prevalent/incident CVD cases.
Discussion
The present study provides valuable evidence regarding the secular trends of cardiovascular diseases risk factors over the past decade in older adults in a high-risk and Figure 1 The secular trends of anthropometrics, blood pressure measures, and lipid and glucose profiles by sex; the Tehran Lipid and Glucose Study (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) . Models for assessment of time trend were fitted separately for men and women, and age-adjusted marginal means and P-values for trend were reported. The effect modification of sex on the trend of risk factors was tested by fitting a model including sex, the risk factor and their cross-product in a pooled model including both sexes. P-values for interaction were calculated using the Wald test. BMI, body mass index; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; non-HDL-C, non-high-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; WC, waist circumference; WHR, Weight to hip circumference. Formula for calculating LDL-C values as follows: LDL-C (mg/dL) = non-HDL-C × 90% -TG × 10%.
understudied Middle Eastern population. Our results showed that not only did the older population have very high levels of CVD risk factors at baseline, but also, over the period of a decade, dramatic increasing trends of CVD risk factors including general and central adiposity, hypertension, diabetes and CKD were observed in both sexes. Conversely, a favorable trend was shown for lipid profile parameters in both sexes and low physical activity in men. The prevalence of smoking among the study population remained steady throughout follow up. During the same period, the rate of medication consumption increased significantly in both sexes. This increase was more prominent for lipid-lowering medications.
Regarding obesity status, significant increases in the rate of general and central adiposity were observed in both sexes. In fact, in 2014 (phase 5), >70% of women and 60% of men showed a central adiposity phenotype. Importantly, the rate of central adiposity was more prominent among women than men. A meta-analysis carried out among 209 166 Iranian individuals showed the trend of Figure 2 The secular trends of cardiovascular disease risk factors by sex; the Tehran Lipid and Glucose Study (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) . Models for assessment of time trend were fitted separately for men and women, and age-adjusted marginal means and P-values for trend were reported. The effect modification of sex on the trend of risk factors was tested by fitting a model including sex, the risk factor and their cross-product in a pooled model including both sexes. P-values for interaction were calculated using the Wald test. Hypertension was defined as, systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg or using antihypertensive medication; diabetes as fasting plasma glucose ≥7 mmol/L or 2-h post-challenge plasma glucose ≥11.1 mmol/L or taking antidiabetic medication; high lowdensity lipoprotein cholesterol (LDL-C) as ≥3.37 mmol/L; high non-high-density lipoprotein cholesterol (HDL-C) as ≥4.14 mmol/L; low HDL-C as ≤1.04 mmol/L for men and ≤1.29 mmol/L for women; high triglycerides as ≥1.69 mmol/L; central obesity as waist circumference ≥95 cm; general obesity as body mass index ≥30 kg/m 2 , physical inactivity <600 metabolic equivalent task-minutes per week; and chronic kidney disease as estimated glomerular filtration rate <60 mL/min/1.73 m 2 .
CVD risk factors trends in elderly © 2017 Japan Geriatrics Society | 5 obesity was similar in both sexes; however, women had almost a constantly higher risk of obesity than men during the recent two decades. 9 Obesity among this older population was generally associated with higher mortality and morbidity, and poorer quality of life. 10 In our recent study, we showed that in the older population, the central adiposity measures confer a significant risk for CVD events.
11 Hence, as acknowledged by the American Society for Nutrition, weight loss therapy should be advised among the older members of the Iranian population who are obese and have functional impairments or metabolic complications, with the aim of minimizing muscle and bone losses. 10 The present results showed increasing trends in the prevalence of diabetes among older adults of both sexes. These results are in line with global diabetes trends, which have increased steadily in developing and developed countries since the 1950s. 12 The prevalence of type 2 diabetes is estimated to increase by 55% worldwide at an alarming pace in developing countries by 2035. 12 Obesity and aging were suggested as the main drivers of the rising trend of type 2 diabetes. 12 Despite the emphasis of international guidelines for commencement of metformin at the same time as lifestyle management at the time of the diagnosis of type 2 diabetes, approximately 27% of women with diabetes and 37% of men with diabetes did not use any antidiabetic medication at the end of follow up in this population. 13 The present finding of a high and increasing prevalence of hypertension in this older population is in line with previous studies in Iran and national data. 14, 15 In our recent study, hypertension was found to be the most powerful mediator of central obesity for CVD events in the elderly population, accounting for 30-45% of the excess risk.
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In eight trials including 15 693 elderly patients with isolated systolic hypertension, active treatment reduced total mortality by 13%, cardiovascular mortality by 18%, all cardiovascular complications by 26%, stroke by 30% and coronary events by 23%. 16 There is an ample amount of evidence that dietary salt intake is the main driver of hypertension, and that a decrease in salt intake leads to a decrease in blood pressure and, in turn, the CVD risk. 17 According to the World Health Organization technical report, daily salt intake should be <5 g (equivalent to approximately 2 g of sodium); however, based on the per capita amount of salt production in the country, experts believe that the average amount of salt consumed in the country is approximately 10-15 g per day. 17 Furthermore, unfortunately, 23% and 35% of hypertensive women and men, respectively, were not receiving any antihypertensive medication at the end of the study.
Similar to the general Iranian population, a favorable trend for lipid profiles was shown among a Tehranian older population, which might be attributable to a significant increase in the rate of lipid-lowering medication consumption. 18 Given that dyslipidemia is prevalent in the Iranian population, the diagnosis and treatment of dyslipidemia has been one of the main goals of the healthcare system in Iran. 19 Furthermore, results from studies in the past decade showed that Iranians consumed a high level of fat, most of which was trans fatty acids. 19 Therefore, the government started extending national plans for the replacement of trans fatty acids with unsaturated fats. The present results might be the results of those national plans. In the current study, we used the traditionally recommended cut-off value of serum LDL-C to classify our population. 20 However, the American Heart Association and American Stroke Association The trends for glucose-lowering and antihypertensive medications were reported in only diabetic and hypertensive subsamples, respectively.
recommendation on statins for primary prevention for patients aged between 40 and 75 years does not recommend any target for lipid profile value. 21 Furthermore, there is no recommendation for older adults aged ≥75 years due to the few clinical trials for this age group. 21 Despite the efforts to ban smoking in public places, smoking did not decrease over the study period in our older population. This finding is in contrast with the declining trend of smoking globally. 22 A recent meta-analysis of 25 cohort studies consisting of 503 905 participants aged >60 years showed that not only smoking is a major independent risk factor of cardiovascular events and increases CVD mortality, but also smoking cessation in older adults is beneficial in reducing the excess risk. 23 Regarding CKD, the present data analysis confirmed rising and similar trends in both sexes; importantly, in 2014, approximately 67% and 51% of the women and men, respectively, suffered from CKD. The prevalence of CKD increased with age globally. A sex difference in the prevalence of CKD with aging was reported. 24 A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease from 2010 showed that, in low-and middle-income countries, CKD was more prevalent among women than men (13.1% vs 9.7%) in the 60-69 years age group. 24 In a collaborative meta-analysis, Matsushita et al. showed the hazardous risk of a lower estimated glomerular filtration rate was a predictor for total and CVD mortality among the population aged less or more than 65 years. 25 The effect of physical activity on CVD outcome in older adults is not consistent. Some data suggested that physical activity in this age group has a hazardous effect, and declared that physical activity might trigger sudden death, especially in people who do not exercise regularly; 26 in contrast, among Japanese older adults, physical activity was shown to have a protective effect on CVD mortality in both the healthy and those with pre-existing disease. 27 In our data analysis, we showed a favorable trend in the level of physical activity only among older men, which might potentially translate to a better outcome. According to Iran's national surveys carried out on 2007 and 2011, the Iranian population, particularly women, has become less active. Furthermore, work-related activity was dramatically decreased in women. 28 The present results regarding the prevalence and trend of CVD risk factors were considerably different between the two sexes. The difference in the prevalence and the trend of the CVD risk factors between men and women was also shown in our previous studies in the same population.
18,29 Such differences should be interpreted considering both physiological and healthrelated behaviors differences between the sexes. It has been suggested that the health-related behaviors of a population are heavily influenced by the historical context of communities and cultural norms. 30 In the INTERHEART global case-control study including 27 098 participants from 52 countries by Anand et al., it was found that the differences between the sexes in the age at first myocardial infarction is largely explained by the higher risk factor levels at younger ages rather than sex-related physiological differences. 30 The present study did however have some limitations; first, the actual burden of the measured risk factors in the community might be underestimated, as inclusion of participants in a cohort study can increase the level of attention they pay to controlling their health risks (cohort effect). Second, the present study design was prone to survival bias, as the participants with very high levels of risk factors could be lost in subsequent phases as a result of death from CVD events or non-CVD causes. However, our results remained essentially unchanged, when we excluded prevalent/incident cases of CVD. Finally, our results cannot be directly extrapolated to other populations because the study was carried out among an ethnically homogenous, older Iranian population.
In conclusion, the present study showed that among an older Iranian population, throughout almost a decade of follow up, lipid parameters including high LDL-C, high TG and low HDL-C had the most decreasing trend; whereas, the trend of diabetes, CKD, hypertension, general and central obesity increased, and no improvement was shown for smoking cessation. The level of physical activity was improved only among men. Despite increasing trends in drug consumption, still approximately 27% of women with diabetes and 37% of men with diabetes did not use antidiabetic medication; the results were 23% and 35% for hypertensive women and men, respectively. Hence, despite the benefits of lipid lowering, the status of other risk factor profiles are often suboptimal. There remains much room for improvement in risk factor management, particularly for hypertension, smoking and central adiposity status, and a need for an intervention.
